Managing Opioid Use Disorder with Medications- Pharmacist

  Price  $6.95

  Credits  1.5



According to the Centers for Disease Control and Prevention (CDC), drug overdose deaths have increased during the COVID-19 pandemic in the US. In fact, over 81,000 drug overdose deaths occurred over a 12-month time period ending in May 2020 – a 38% increase over the 12-month period through May of 2019. Synthetic opioids, specifically illicitly manufactured fentanyl, appear to be the driver behind this increase. Opioid use and associated overdoses may continue to rise as the long-term consequences of the pandemic (eg, job loss, lost relationships, anxiety, depression) become palpable. CDC recommendations for the prevention of opioid overdoses include expanded access to the life-saving opioid reversal medication naloxone, overdose prevention education efforts, and awareness of treatment options for opioid use disorder. The CDC’s Rx Awareness campaign highlights personal stories of individuals impacted by prescription opioid abuse, to shed light on this important topic, reduce the stigma, and educate the public about treatment options. Opioid use disorder (OUD) can involve misuse of opioid prescription medications, use of diverted drugs, or illicit heroin and fentanyl use. OUD is typically a chronic, relapsing illness, linked with a significantly increased risk of death.


Subscribe and Save. Get access to this course PLUS the Rx Resource Library!

Explore Our Subscription Options

Course Information

Target Audience


Jennifer Gershman
PharmD, CPh
Knowledge Level

General Overview

This activity will apply to a broad range of learning needs/pharmacy settings. It may include common disease state/therapy overivews and/or general pharmacy needs such as medication errors, immunizations, or law topics.

Learning Objectives

  • Discuss prescription drug abuse prevention strategies, including education campaigns such as Rx Awareness; risk factors for opioid use disorder (OUD); and validated screening tools.
  • Compare and contrast the 3 FDA-approved medications (buprenorphine, methadone, and naltrexone) for the treatment of OUD, including dosing, side effects, and drug interactions.
  • Identify the role of naloxone when prescribing or dispensing opioid medications. List important administration counseling points for patients, family, friends, and caregivers.

Course Accreditation

  • Activity Type:
  • CE Broker
  • Universal Activity Number:
    Pharmacist : 0798-0000-21-219-H08-P
PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

Credit for this program is issued by passing the final test hosted at with a score of 70% or higher.

Technology Requirements

  • Hardware Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Software Requirements
    Standard Windows/Mac System
    iPad or iPhone
    Minimum screen resolution: 1024x768
  • Network Requirements
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.